Bunn Paul A. 4
4 · Verastem, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Verastem, Inc.VSTM
Bunn Paul A.
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2025-11-21−6,250→ 6,250 totalExercise: $3.27Exp: 2034-06-18→ Common Stock (6,250 underlying) - Sale
Common Stock
2025-11-21$10.00/sh−6,250$62,500→ 2,083 total - Exercise/Conversion
Common Stock
2025-11-21$3.27/sh+6,250$20,438→ 8,333 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
- [F3]The stock option vested in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion vested). The first eleven installments vested beginning on the last day of the month over the period from June, 2024 to April, 2025 and the last installment vested on the day before the 2025 Annual Meeting of Stockholders.